Qiang Xiong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Qiang Xiong has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Dexing Lian
National Center for Occupational Safety and Health, National Health Commission of the People’s Republic of China, Beijing, China
1 shared publicationJianliang Peng
National Center for Occupational Safety and Health, National Health Commission of the People’s Republic of China, Beijing, China
1 shared publicationJing Liang
National Center for Occupational Safety and Health, National Health Commission of the People’s Republic of China, Beijing, China
1 shared publication- Kuke Ding
National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention, Xicheng District, Beijing 100088, P. R. China
1 shared publication - Lixin Ding
National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention, Xicheng District, Beijing 100088, P. R. China
1 shared publication Lulu Wang
National Center for Occupational Safety and Health, National Health Commission of the People’s Republic of China, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 2 May 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1593415
Epidemiological trends of lung cancer attributed to residential radon exposure at global, regional, and national level: a trend analysis study from 1990 to 2021
Background: Lung cancer (LC) remains a leading cause of cancer-related mortality globally, with radon identified as the second major risk factor. This study aimed to analyze the global, regional, and national burden of LC attributed to residential radon exposure from 1990 to 2021.Methods: The Global Burden of Disease (GBD) 2021 database were employed to estimate the disease trends of LC attributed to residential radon exposure across sex, age groups, and socioeconomic development levels via the socio-demographic index (SDI). Trends of the age-standardized rates (ASRs) were evaluated using estimated annual percentage change (EAPC). The relationship of the socio-demographic index (SDI) with ASRs was assessed via Spearman correlation and LOESS regression.Results: In 2021, residential radon caused 82,160 global LC deaths (an increase of 66.87% since 1990), while the ASRs declined globally (ASMR EAPC: −0.26, 95%C: −0.51 to −0.01; ASDR EAPC: −0.65, 95%CI: −0.85 to −0.44). The disease burden of residential radon-induced LC was higher in middle and high latitude nations. With the increase of SDI, ASRs showed a downward trend in most regions, while an upward trend at national level. Across age and sex, the older adult males exhibited higher burden.Conclusion: While global ASRs declined, rising absolute burdens underscore radon’s persistent threat, particularly in rapidly urbanizing and high-latitude regions. Targeted radon mitigation, enhanced early detection, and gender-specific interventions are critical.
- 2 May 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1593415
Open AccessEpidemiological trends of lung cancer attributed to residential radon exposure at global, regional, and national level: a trend analysis study from 1990 to 2021
Background: Lung cancer (LC) remains a leading cause of cancer-related mortality globally, with radon identified as the second major risk factor. This study aimed to analyze the global, regional, and national burden of LC attributed to residential radon exposure from 1990 to 2021.Methods: The Global Burden of Disease (GBD) 2021 database were employed to estimate the disease trends of LC attributed to residential radon exposure across sex, age groups, and socioeconomic development levels via the socio-demographic index (SDI). Trends of the age-standardized rates (ASRs) were evaluated using estimated annual percentage change (EAPC). The relationship of the socio-demographic index (SDI) with ASRs was assessed via Spearman correlation and LOESS regression.Results: In 2021, residential radon caused 82,160 global LC deaths (an increase of 66.87% since 1990), while the ASRs declined globally (ASMR EAPC: −0.26, 95%C: −0.51 to −0.01; ASDR EAPC: −0.65, 95%CI: −0.85 to −0.44). The disease burden of residential radon-induced LC was higher in middle and high latitude nations. With the increase of SDI, ASRs showed a downward trend in most regions, while an upward trend at national level. Across age and sex, the older adult males exhibited higher burden.Conclusion: While global ASRs declined, rising absolute burdens underscore radon’s persistent threat, particularly in rapidly urbanizing and high-latitude regions. Targeted radon mitigation, enhanced early detection, and gender-specific interventions are critical.
- Open Access
- 29 July 2021
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 10 (4) , 875-884
Cdc25B is transcriptionally inhibited by IER5 through the NF-YB transcription factor in irradiation-treated HeLa cells
Cervical cancer (CC) is a type of pelvic malignant tumor that severely threatens women's health. Current evidence suggests that IER5, as a potential radiosensitizer, promotes irradiation-induced apoptosis in CC tissues in patients undergoing chemoradiotherapy. IER5 has been shown to be involved in the G2/M-phase transition. In the present study, we used Cdc25B as the breakthrough point to explore the underlying mechanism of IER5 in the cell cycle regulation of radiation-damaged HeLa cells. IER5 was evidently upregulated after irradiation, but Cdc25B was significantly downregulated. In monoclonal IER5-silenced HeLa cells, irradiation-induced downregulation of Cdc25B was attenuated. The effect of irradiation on Cdc25B promoter activity was determined by dual-luciferase reporter assays. The response elements on the Cdc25B promoter related to irradiation were predicted by JASPAR. These conserved sequences were mutated individually or in combination by splicing-by-overlap extension PCR, and their function was confirmed by dual-luciferase reporter assays. The enrichment efficiency of transcription factors after irradiation was determined by chromatin immunoprecipitation (ChIP) assay. Both Sp1/Sp3 and NF-YB binding sites were involved in irradiation-mediated regulation of Cdc25B. IER5 was involved in irradiation-mediated regulation of Cdc25B through the NF-YB binding site. Furthermore, ChIP assays showed that IER5 bound to the Cdc25B promoter, and the binding of IER5 to the Cdc25B promoter region in irradiation-induced HeLa cells induced the release of the coactivator p300 through interaction with NF-YB. Taken together, these findings indicate that IER5 is the transcriptional repressor that accelerates the downregulation of Cdc25B expression after irradiation.
- 29 July 2021
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 10 (4) , 875-884
Open AccessCdc25B is transcriptionally inhibited by IER5 through the NF-YB transcription factor in irradiation-treated HeLa cells
Cervical cancer (CC) is a type of pelvic malignant tumor that severely threatens women's health. Current evidence suggests that IER5, as a potential radiosensitizer, promotes irradiation-induced apoptosis in CC tissues in patients undergoing chemoradiotherapy. IER5 has been shown to be involved in the G2/M-phase transition. In the present study, we used Cdc25B as the breakthrough point to explore the underlying mechanism of IER5 in the cell cycle regulation of radiation-damaged HeLa cells. IER5 was evidently upregulated after irradiation, but Cdc25B was significantly downregulated. In monoclonal IER5-silenced HeLa cells, irradiation-induced downregulation of Cdc25B was attenuated. The effect of irradiation on Cdc25B promoter activity was determined by dual-luciferase reporter assays. The response elements on the Cdc25B promoter related to irradiation were predicted by JASPAR. These conserved sequences were mutated individually or in combination by splicing-by-overlap extension PCR, and their function was confirmed by dual-luciferase reporter assays. The enrichment efficiency of transcription factors after irradiation was determined by chromatin immunoprecipitation (ChIP) assay. Both Sp1/Sp3 and NF-YB binding sites were involved in irradiation-mediated regulation of Cdc25B. IER5 was involved in irradiation-mediated regulation of Cdc25B through the NF-YB binding site. Furthermore, ChIP assays showed that IER5 bound to the Cdc25B promoter, and the binding of IER5 to the Cdc25B promoter region in irradiation-induced HeLa cells induced the release of the coactivator p300 through interaction with NF-YB. Taken together, these findings indicate that IER5 is the transcriptional repressor that accelerates the downregulation of Cdc25B expression after irradiation.